118 related articles for article (PubMed ID: 8529488)
1. Effects of metformin in obese patients with impaired glucose tolerance.
Scheen AJ; Letiexhe MR; Lefèbvre PJ
Diabetes Metab Rev; 1995 Sep; 11 Suppl 1():S69-80. PubMed ID: 8529488
[No Abstract] [Full Text] [Related]
2. [Characteristic of metformin for treatment of impaired glucose tolerance].
Ishida W; Satoh J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
[No Abstract] [Full Text] [Related]
3. Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance.
Morel Y; Golay A; Perneger T; Lehmann T; Vadas L; Pasik C; Reaven GM
Diabet Med; 1999 Aug; 16(8):650-5. PubMed ID: 10477209
[TBL] [Abstract][Full Text] [Related]
4. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
5. [Effects of nateglinide in impaired glucose tolerance subjects].
Hirose T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():438-43. PubMed ID: 15779419
[No Abstract] [Full Text] [Related]
6. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
[TBL] [Abstract][Full Text] [Related]
7. Is troglitazone a real indication for obese subjects with impaired glucose tolerance?
Yoshioka K; Yokoo S; Yoshida T; Kondo M
Diabetes Care; 1997 Aug; 20(8):1340-1. PubMed ID: 9250469
[No Abstract] [Full Text] [Related]
8. Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance.
Scheen AJ; Letiexhe MR; Lefèbvre PJ
Diabet Med; 1995 Nov; 12(11):985-9. PubMed ID: 8582131
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
10. Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.
Osei E; Fonville S; Zandbergen AA; Brouwers PJ; Mulder LJ; Lingsma HF; Dippel DW; Koudstaal PJ; den Hertog HM
Trials; 2015 Aug; 16():332. PubMed ID: 26242578
[TBL] [Abstract][Full Text] [Related]
11. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin on patients with impaired glucose tolerance.
Li CL; Pan CY; Lu JM; Zhu Y; Wang JH; Deng XX; Xia FC; Wang HZ; Wang HY
Diabet Med; 1999 Jun; 16(6):477-81. PubMed ID: 10391395
[TBL] [Abstract][Full Text] [Related]
13. Is metformin more than an oral hypoglycaemic agent?
Vague P
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S5-7. PubMed ID: 14502095
[No Abstract] [Full Text] [Related]
14. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
Retnakaran R; Ye C; Hanley AJ; Harris SB; Zinman B
Diabetes Obes Metab; 2012 Jan; 14(1):91-3. PubMed ID: 21812893
[TBL] [Abstract][Full Text] [Related]
15. Treatment of impaired glucose tolerance in childhood.
Caprio S
Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):320-1. PubMed ID: 18414464
[No Abstract] [Full Text] [Related]
16. [Treatment for coronary artery disease patients with impaired glucose tolerance].
Kume A; Miyazaki T; Daida H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():543-7. PubMed ID: 15779438
[No Abstract] [Full Text] [Related]
17. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance.
Kosegawa I; Katayama S; Kikuchi C; Kashiwabara H; Negishi K; Ishii J; Inukai K; Oka Y
Hypertens Res; 1996 Mar; 19(1):37-41. PubMed ID: 8829822
[TBL] [Abstract][Full Text] [Related]
18. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome.
Ehrmann DA
N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
[No Abstract] [Full Text] [Related]
20. Administration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male Rats.
Thomas AP; Hoang J; Vongbunyong K; Nguyen A; Rakshit K; Matveyenko AV
Endocrinology; 2016 Dec; 157(12):4720-4731. PubMed ID: 27653034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
